Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol vs sufentanil induction for PONV in elderly laparoscopic GI surgery
ChiCTR2100045860Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of butorphanol in postoperative nausea and vomiting (PONV) (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Postoperative nausea and vomiting. Started May 2021; status: recruiting.
02
Drugs
butorphanol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2100045860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045860.